Clinical course after cardiac resynchronization therapy in transthyretin amyloid cardiomyopathy receiving disease-modifying therapy. - Yamauchi S; Kondo H; Mitarai K; Yonezu K; Saito S; Shinohara T; Fukui A; Hirota K; Kodama H; Kodama N; Zaizen T; Takahashi M; et al. (Heart and vessels, 2026)